# US 2001/0024796 A1 · Methods for parallel detection of compositions having desired characteristics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2001/0024796 A1
- Document ID: US20010024796A1
- Status: Published application
- Kind: A1
- Application number: 09/738,544
- Filed: 2000-12-15
- Published: 2001-09-27
- Earliest claimed: 1999-12-17
- Inventors: Sergey A. Selifonov; Gjalt W. Huisman
- Web page: https://patentgrep.com/patent/US20010024796A1

## CPC

- G01R 33/4625: {Processing of acquired signals, e.g. elimination of phase errors, baseline fitting, chemometric analysis}
- B01J 2219/00587: High throughput processes
- B01J 2219/00596: Solid-phase processes
- B01J 2219/00605: the compounds being directly bound or immobilised to solid supports
- B01J 2219/0061: The surface being organic
- B01J 2219/00612: the surface being inorganic
- B01J 2219/0063: Other, e.g. van der Waals forces, hydrogen bonding
- B01J 2219/00659: Two-dimensional arrays
- B01J 2219/00707: separated from the reactor apparatus
- B01J 2219/0072: Organic compounds
- G01R 33/483: with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
- G01R: MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES (indicating correct tuning of resonant circuits H03J3/12)
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS

## Abstract

Methods and apparatuses for performing high throughput magnetic resonance imaging spectroscopy, e.g., to screen libraries of chemical or biological compositions for a compound of interest, are provided. Methods of identifying metabolic disorder genes, modulatory compounds and catalysts, and methods of optimizing reaction conditions, using high throughout MRI screening, are also provided.

## Claims

### Claim 1

A method of screening a plurality of samples for a selected property, the method comprising:
(i) providing an artificially generated physical array, which physical array comprises one or more samples at each of a plurality of spatial locations;
(ii) placing the physical array in a magnetic field or applying a magnetic field to the physical array;
(iii) performing magnetic resonance imaging spectroscopy (MRI) on the one or more samples of the physical array, thereby identifying the spatial location for each of the one or more samples having one or more MRI detectable chemical shifts, which one or more chemical shifts correspond to the selected property, thereby screening the plurality of samples for the selected property.

### Claim 2 (depends on 1)

The method of claim 1, wherein each member of the plurality of samples comprises one or more atomic nuclei and the performing MRI comprises:
(a) exciting the one or more atomic nuclei, thereby producing a plurality of signals;
(b) detecting the plurality of signals;
(c) generating one or more images from the plurality of signals, which one or more images correspond to the plurality of spatial locations;
(d) analyzing the one or more images for the presence of one or more selected chemical shifts; which one or more selected chemical shifts correspond to the selected property; and,
(e) deconvoluting the one or more images and the one or more selected chemical shifts to provide the spatial location for each of the one or more samples having the selected property, thereby screening the plurality of samples for the selected property.

### Claim 3 (depends on 1)

The method of claim 1, wherein the physical array comprises a uniform array.

### Claim 4 (depends on 1)

The method of claim 1, further comprising positioning the one or more samples of the physical array within one plane.

### Claim 5 (depends on 1)

The method of claim 1, further comprising positioning the one or more samples of the physical array within multiple planes.

### Claim 6 (depends on 1)

The method of claim 1, wherein the physical array comprises a cylindrical array, a square array, a cubical array, or a rectangular array.

### Claim 7 (depends on 1)

The method of claim 1, comprising positioning the physical array within a cylindrical structure, a square structure, a cubical structure, or a rectangular structure.

### Claim 8 (depends on 6)

The method of claim 6, wherein the cylindrical array has a diameter of about 20 cm and a length of about 24 cm.

### Claim 9 (depends on 1)

The method of claim 1, further comprising constructing the physical array to comprise one or more microwell plates.

### Claim 10 (depends on 1)

The method of claim 1, comprising constructing the physical array to comprise paraffin-filled outer walls.

### Claim 11 (depends on 1)

The method of claim 1, comprising surrounding the physical array with water.

### Claim 12 (depends on 9)

The method of claim 9, wherein the one or more microwell plates comprise one or more 24-well plates, 96-well plates, 384-well plates, or 1536-well plates.

### Claim 13 (depends on 12)

The method of claim 12, comprising providing at least about 24, about 48, about 72, about 96, about 192, about 288, about 384, about 768, about 1152, or about 1536 different spatial locations.

### Claim 14 (depends on 1)

The method of claim 1, wherein the one or more samples comprise at least about 12 to about 10,000 samples.

### Claim 15 (depends on 1)

The method of claim 1, wherein the one or more samples comprise at least about 24, about 48, about 72, about 96, about 192, about 288, about 384, about 768, about 1152, about 1536, about 3072, about 4068, or about 6144 samples.

### Claim 16 (depends on 1)

The method of claim 1, providing the one or more samples to comprise a library of biological compositions.

### Claim 17 (depends on 16)

The method of claim 16, wherein the library of biological compositions comprises a library of mutated cells.

### Claim 18 (depends on 16)

The method of claim 16, wherein the library of biological compositions comprises one or more expression products.

### Claim 19 (depends on 18)

The method of claim 18, further comprising expressing a library of variant genes to produce the one or more expression products.

### Claim 20 (depends on 19)

The method of claim 19, further comprising generating the library of variant genes by DNA shuffling, random mutagenesis, or combinatorial gene assembly.

### Claim 21 (depends on 1)

The method of claim 1, wherein the one or more samples comprise one or more chemical catalysts.

### Claim 22 (depends on 1)

The method of claim 1, wherein the one or more samples comprise one or more of: a microbial cell culture, a cell biomass, a culture broth, an extract, a reaction mixture, a chemical catalyst mixture, a plant tissue sample, a fruit sample, a root sample, a tuber sample, and a plant seed.

### Claim 23 (depends on 1)

The method of claim 1, wherein the one or more samples comprise one or more MRI-active compounds.

### Claim 24 (depends on 23)

The method of claim 23, wherein the one or more MRI-active compounds comprise one or more of: 1H, 13C, 15N, 33S, 31P, and 19F.

### Claim 25 (depends on 1)

The method of claim 1, wherein the one or more samples comprise one or more chiral shift reagents.

### Claim 26 (depends on 1)

The method of claim 1, wherein the one or more samples comprise one or more paramagnetic or ferromagnetic ions and the desired characteristic is metal uptake.

### Claim 27 (depends on 1)

The method of claim 1, wherein each sample has a standard volume, a standard size, and a standard geometry.

### Claim 28 (depends on 27)

The method of claim 27, wherein the standard volume ranges from about 1 μl to about 20 ml.

### Claim 29 (depends on 28)

The method of claim 28, wherein the standard volume ranges from about 100 μl to about 10 ml.

### Claim 30 (depends on 29)

The method of claim 29, wherein the standard volume is about 1.5 ml to about 2.0 ml.

### Claim 31 (depends on 1)

The method of claim 1, wherein the selected property is a selected pH and performing MRI comprises measuring a phenolic proton signal corresponding to each sample.

### Claim 32 (depends on 1)

The method of claim 1, wherein the selected property is a selected amount of a compound of interest or the presence of a compound of interest in the one or more samples.

### Claim 33 (depends on 32)

The method of claim 32, wherein the compound of interest is selected from: an alcohol, a polyol, a carboxylic acid, a lactone, an ester, a polyhydroxyalkanoate, a terpenoid, a carotenoid, a steroid, a polyketide, a lipid, a triglyceride, an aromatic, an amino acid, an alkene, a vitamin, a halogenated organic compound, a benzene bioconversion product, a toluene bioconversion product, an ethylbenzene bioconversion product, a xylene bioconversion product, a monosaccharide, and a polysaccharide.

### Claim 34 (depends on 32)

The method of claim 32, wherein the compound of interest is selected from: lactate, citrate, tylosin, 1,3-propanediol, succinate, glycerol, itaconate, PHB/PHA, lysine, threonine, isoleucine, methionine, tryptophan, phenylalanine, tyrosine, valine, glutamate, aspartate, histidine, phytohaemagglutinin-A, phytohaemagglutinin-B, p-hydroxybenzoate, 3-hydroxybutyrate, aspartame, and δ-caprolactone.

### Claim 35 (depends on 1)

The method of claim 1, wherein step (iii) comprises providing a comparison of the absolute or relative amount of a compound of interest in each sample.

### Claim 36 (depends on 1)

The method of claim 1, wherein step (iii) comprises simultaneously measuring one or more selected chemical shifts for each of the one or more samples, which one or more selected chemical shifts correspond to the selected property.

### Claim 37 (depends on 1)

The method of claim 1, wherein the plurality of samples comprises of one or more microbial strains expressing a library of shuffled genes, a genomic library, or a library of mutated cells and wherein performing MRI comprises comparing an expression level for each member of the library of shuffled genes or of the genomic library.

### Claim 38 (depends on 1)

The method of claim 1, wherein step (iii) comprises comparing performance of a selected biological composition under two or more different conditions.

### Claim 39 (depends on 1)

The method of claim 1, wherein step (iii) comprises applying spiral-based k-space trajectories.

### Claim 40 (depends on 1)

The method of claim 1, wherein the magnetic field comprises a magnetic field strength of about 1.5 Tesla or more.

### Claim 41 (depends on 1)

The method of claim 1, further comprising screening the plurality of samples at a rate of at least about 3000 samples per hour to about 50,000 samples per hour.

### Claim 42 (depends on 41)

The method of claim 41, further comprising screening the plurality of samples at a rate of at least about 5000 samples to about 50,000 samples per hour.

### Claim 43 (depends on 41)

The method of claim 41, further comprising screening the plurality of samples at a rate of at least about 10,000 samples to about 50,000 samples per hour.

### Claim 44 (depends on 41)

The method of claim 41, further comprising screening the plurality of samples at a rate of at least about 20,000 samples to about 50,000 samples per hour.

### Claim 45

An apparatus for screening a plurality of samples, the apparatus comprising:
(i) a magnetic resonance imaging spectrometer; and,
(ii) at least one microwell plate or other artificially generated physical array, wherein during operation of the apparatus the at least one microwell plate or other artificially generated physical array is positioned within a magnetic field produced by the magnetic resonance imaging spectrometer.

### Claim 46 (depends on 45)

The apparatus of claim 45, wherein the magnetic field comprises a field strength of about 1.5 Tesla or more.

### Claim 47 (depends on 45)

The apparatus of claim 45, wherein the at least one microwell plate or other artificially generated physical array comprises one or more 24-well plates, 96-well plates, 384-well plates, or 1536-well plates.

### Claim 48 (depends on 45)

The apparatus of claim 45, wherein the at least one microwell plate or other artificially generated physical array comprises at least about 24, about 48, about 72, about 96, about 192, about 288, about 384, about 768, about 1152, about 1536, about 3072, about 4068, or about 6144 spatially separated samples.

### Claim 49 (depends on 48)

The apparatus of claim 48, wherein the spatially separated samples each comprise a volume of about 1 μl to about 20 ml.

### Claim 50 (depends on 49)

The apparatus of claim 49, wherein the spatially separated samples each comprise a volume of about 100 μl ml to about 10 ml.

### Claim 51 (depends on 50)

The apparatus of claim 50, wherein the spatially separated samples each comprise a volume of about 1.5 ml to about 2.0 ml.

### Claim 52 (depends on 45)

The apparatus of claim 45, wherein the at least one microwell plate or other artificially generated physical array comprises one or more spatially separated sample compartments, which spatially separated sample compartments are positioned within a single plane.

### Claim 53 (depends on 45)

The apparatus of claim 45, wherein the at least one microwell plate or other artificially generated physical array comprises one or more spatially separated sample compartments, which spatially separated sample compartments are positioned within multiple planes.

### Claim 54 (depends on 45)

The apparatus of claim 45, wherein the at least one microwell plate or other artificially generated physical array comprises a cylindrical array, a square array or a cubical array.

### Claim 55 (depends on 45)

The apparatus of claim 45, wherein the at least one microwell plate or other artificially generated physical array is positioned within a cylindrical structure.

### Claim 56 (depends on 55)

The apparatus of claim 55, wherein the cylindrical structure comprises a diameter of about 20 cm and a length of about 24 cm.

### Claim 57 (depends on 45)

The apparatus of claim 45, wherein the at least one microwell plate or other artificially generated physical array has at least one outer wall, which outer wall is a paraffin-filled outer wall.

### Claim 58 (depends on 45)

The apparatus of claim 45, wherein the at least one microwell plate or other artificially generated physical array is surrounded by water or filled with water.

### Claim 59 (depends on 45)

The apparatus of claim 45, further comprising an automatic sampler operably coupled to the magnetic resonance imaging spectrometer, which automatic sampler positions the at least one microwell plate or other artificially generated physical array within the magnetic resonance imaging spectrometer.

### Claim 60 (depends on 45)

The apparatus of claim 45, further comprising a detector operably coupled to the spectrometer, which detector detects signals generated by operation of the magnetic resonance imaging spectrometer.

### Claim 61 (depends on 45)

The apparatus of claim 45, further comprising a computer and software operably coupled to the apparatus for recording and analyzing data from the magnetic resonance imaging spectrometer.

### Claim 62 (depends on 45)

The apparatus of claim 45, wherein during operation, the apparatus screens the plurality of samples at a rate of at least about 3000 samples to about 50,000 samples per hour.

### Claim 63 (depends on 62)

The apparatus of claim 62, wherein during operation, the apparatus screens the plurality of samples at a rate of at least about 5000 samples to about 50,000 samples per hour.

### Claim 64 (depends on 62)

The apparatus of claim 62, wherein during operation, the apparatus screens the plurality of samples at a rate of at least about 10,000 samples to about 50,000 samples per hour.

### Claim 65 (depends on 62)

The apparatus of claim 62, wherein during operation, the apparatus screens the plurality of samples at a rate of at least about 20,000 samples to about 50,000 samples per hour.

### Claim 66

A method of identifying metabolic disorder genes, the method comprising:
(i) providing a plurality of cells, which cells comprise a library of mutated cells or have been transformed with a plasmid containing one or more members of a library of gene sequences, which cells produce one or more metabolites;
(ii) performing magnetic resonance imaging (MRI) spectroscopy on the plurality of cells or on the one or more metabolites, thereby detecting the one or more metabolites;
(iii) identifying one or more cells that produce a reduced or increased level of at least one of the one or more metabolites, as compared to a standard, thereby identifying one or more metabolic disorder genes.

### Claim 67 (depends on 66)

The method of claim 66, wherein the metabolic disorder is colon cancer, batten disease, deafness distonia syndrome, or lupus nephritis

### Claim 68

A method of identifying a modulatory compound, the method comprising:
(i) providing a plurality of cells, which cells comprises a library of mutated cells or have been transformed with a plasmid containing one or more members of a library of gene sequences, which cells produce one or more metabolites;
(ii) performing magnetic resonance (MRI) spectroscopy on the plurality of cells or on the one or more metabolites, thereby detecting the one or more metabolites;
(iii) identifying one or more cells that produce a reduced or increased level of at least one of the one or more metabolites, as compared to a standard;
(iv) screening a plurality of potential modulatory compounds by MRI spectroscopy for alleviation of the reduced or increased level of the at least one of the one or more metabolites;
(v) identifying one or more of the plurality of potential modulatory compounds that alleviate the reduced or increased level of the at least one of the one or more metabolites, thereby identifying a modulatory compound.

### Claim 69 (depends on 68)

The method of claim 68, wherein step (iv) comprises:
incubating the plurality of cells with the plurality of potential modulatory compounds;
performing MRI spectroscopy on the plurality of cells or on the one or more metabolites, thereby detecting the one or more metabolites produced by the plurality of cells in the presence of the one or more potential modulatory compounds;
comparing the one or more metabolites produced by the plurality of cells in the presence of the one or more modulatory compounds with the one or more metabolites produced in step (i).

### Claim 70 (depends on 69)

The method of claim 69, wherein comparing comprises quantifying the amount of the one or more metabolites produced in the presence of the one or more modulatory compounds.

### Claim 71 (depends on 68)

The method of claim 68, wherein the one or more potential modulatory compounds comprise one or more of: a peptide, a protein, a metabolic product, a carbohydrate, a lipid, a nucleic acid, a nucleotide, an oligonucleotide, a small organic molecule, and combinations thereof.

### Claim 72 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the plurality of cells comprises one or more of: a yeast cell, a bacterial cell, a plant cell, a tissue culture, a callus culture, an insect cell, a germinating seed, a hatching egg cell, and a developing embryo cell.

### Claim 73 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the plurality of cells comprises a plurality of mutant Saccharomyces cerevisiae cells.

### Claim 74 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the library of gene sequences comprises at least about 1000 or more, about 5000 or more, about 10,000 or more, or about 100,000 or more members.

### Claim 75 (depends on 66, 68)

The method of claim 66 or claim 68, further comprising generating the library of gene sequences by DNA shuffling, random mutagenesis, transposon mutagenesis, or combinatorial gene assembly.

### Claim 76 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the library of gene sequences comprises a library of related gene sequences.

### Claim 77 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the library of related gene sequences comprises one or more colon cancer genes, one or more batten disease genes, one or more deafness distoria genes, or one or more lupus nephritis genes.

### Claim 78 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the one or more metabolites comprise at least one MRI-active compound.

### Claim 79 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the one or more metabolites include one or more of: ethanol, lactate, citrate, tylosin, 1,3-propanediol, succinate, glycerol, itaconate, PHB/PHA, lysine, threonine, isoleucine, methionine, tryptophan, phenylalanine, tyrosine, valine, glutamate, aspartate, histidine, phytohaemagglutinin-A, phytohaemagglutinin-B, p-hydroxybenzoate, 3-hydroxybutyrate, aspartame, and δ-caprolactone.

### Claim 80 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the one or more metabolites include one or more of: an alcohol, a polyol, a carboxylic acid, a lactone, an ester, a polyhydroxyalkanoate, a terpenoid, a carotenoid, a steroid, a sterol, a fatty acid, a polyketide, a lipid, a triglyceride, an aromatic, an amino acid, an alkene, a vitamin, a halogenated organic compound, a benzene bioconversion product, a toluene bioconversion product, an ethylbenzene bioconversion product, a xylene bioconversion product, a monosaccharide, and a polysaccharide.

### Claim 81 (depends on 66, 68)

The method of claim 66 or claim 68, wherein the plurality of cells comprises a plurality of mutant cells and the standard comprises a non-mutant cell.

### Claim 82 (depends on 66, 68)

The method of claim 66 or claim 68, the method further comprising quantifying an amount of the one or more metabolites produced by each member of the plurality of cells.

### Claim 83 (depends on 66, 68)

The method of claim 66 or claim 68, comprising simultaneously performing MRI spectroscopy on each member of the plurality of cells, thereby simultaneously detecting the one or more metabolites.

### Claim 84 (depends on 66, 68)

The method of claim 66 or claim 68, comprising simultaneously screening at least 3000 to about 50,000 library members in about 1 hour or less.

### Claim 85 (depends on 66, 68)

The method of claim 66 or claim 68, further comprising screening the library of gene sequences at a rate of at least about 3000 to about 50,000 members per hour.

### Claim 86 (depends on 66, 68)

The method of claim 66 or claim 68, further comprising screening the library of gene sequences at a rate of at least about 5000 to about 50,000 members per hour.

### Claim 87 (depends on 66, 68)

The method of claim 66 or claim 68, further comprising screening the library of gene sequences at a rate of at least about 10,000 to about 50,000 members per hour.

### Claim 88 (depends on 66, 68)

The method of claim 66 or claim 68, further comprising screening the library of gene sequences at a rate of at least about 20,000 to about 50,000 members per hour.

### Claim 89 (depends on 66, 68)

The method of claim 66 or claim 68, wherein performing MRI spectroscopy on the plurality of cells or screening a plurality of potential modulatory compounds by MRI spectroscopy comprises:
(a) providing an artificially generated physical array, which physical array comprises a plurality of spatial locations; wherein each member of the plurality of spatial locations comprises at least one member of the plurality of cells, which at least one member of the plurality of cells comprises at least one member of the library of gene sequences.
(b) placing the physical array in a magnetic field or applying a magnetic field to the physical array; and
(c) performing MRI spectroscopy on plurality of cells within the physical array, thereby identifying the spatial location for each of the one or more cells that produce a reduced or increased level of at least one of the one or more metabolites as compared to the standard.

### Claim 90 (depends on 89)

The method of claim 89, wherein step (c) comprises:
(d) exciting one or more atomic nuclei in the one or more metabolites, thereby producing a plurality of signals;
(e) detecting the plurality of signals;
(f) generating one or more images from the plurality of signals, which one or more images correspond to the plurality of spatial locations;
(g) analyzing the one or more images for the presence of one or more selected chemical shifts; which one or more selected chemical shifts correspond to the one or more metabolites; and,
(h) deconvoluting the one or more images and the one or more selected chemical shifts to provide the spatial location for each of the one or more cells having the one or more metabolites.

### Claim 91 (depends on 89)

The method of claim 89, wherein the physical array comprises a uniform array.

### Claim 92 (depends on 89)

The method of claim 89, further comprising positioning the plurality of cells or the one or more metabolites within one plane in the physical array.

### Claim 93 (depends on 89)

The method of claim 89, further comprising positioning the plurality of cells or the one or more metabolites within multiple planes in the physical array.

### Claim 94 (depends on 89)

The method of claim 89, wherein the physical array comprises a cylindrical array, a square array, a cubical array, or a rectangular array.

### Claim 95 (depends on 89)

The method of claim 89, comprising positioning the physical array within a cylindrical structure, a square structure, a cubical structure, or a rectangular structure.

### Claim 96 (depends on 95)

The method of claim 95, wherein the cylindrical array has a diameter of about 20 cm and a length of about 24 cm.

### Claim 97 (depends on 89)

The method of claim 89, further comprising constructing the physical array to comprise one or more microwell plates.

### Claim 98 (depends on 89)

The method of claim 89, comprising constructing the physical array to comprise paraffin-filled outer walls.

### Claim 99 (depends on 89)

The method of claim 89, comprising surrounding the physical array with water.

### Claim 100 (depends on 97)

The method of claim 97, wherein the one or more microwell plates comprise one or more 24-well plates, 96-well plates, 384-well plates, or 1536-well plates.

### Claim 101 (depends on 100)

The method of claim 100, comprising providing at least about 24, about 48, about 72, about 96, about 192, about 288, about 384, about 768, about 1152, or about 1536 different spatial locations.

### Claim 102 (depends on 89)

The method of claim 89, wherein the plurality of cells comprises at least about 12 to about 50,000 samples.

### Claim 103 (depends on 89)

The method of claim 89, wherein the plurality of cells comprises at least about 24, about 48, about 72, about 96, about 192, about 288, about 384, about 768, about 1152, about 1536, about 3072, about 4068, or about 6144 samples.

### Claim 104 (depends on 89)

The method of claim 89, wherein step (c) comprises applying spiral-based k-space trajectories.

### Claim 105 (depends on 89)

The method of claim 89, wherein the magnetic field comprises a magnetic field strength of about 1.5 Tesla or more.

### Claim 106 (depends on 89)

The method of claim 89, further comprising screening at least about 3500 samples, about 5000 samples, about 10,000 samples, about 20,000, or about 50,000 samples per hour.

### Claim 107

A method of identifying a catalyst, the method comprising:
(i) providing a plurality of assay solutions, which plurality of assay solutions comprises at least one reactant;
(ii) providing a plurality of catalysts;
(iii) combining the plurality of assay solutions and the plurality of catalysts;
(iv) performing magnetic resonance (MRI) spectroscopy on the plurality of assay solutions, thereby detecting one or more products generated by an action of one or more members of the plurality of catalysts on the at least one reactant; and
(v) identifying one or more members of the plurality of catalysts that alter the level of the at least one of the one or more products, thereby identifying a catalyst.

### Claim 108 (depends on 107)

The method of claim 107, wherein the catalyst comprises a chemical catalyst or a biological catalyst.

### Claim 109 (depends on 107)

The method of claim 107, wherein the plurality of catalysts comprises a plurality of cells.

### Claim 110 (depends on 107)

The method of claim 107, wherein the plurality of catalysts comprises a library of compounds.

### Claim 111 (depends on 107)

The method of claim 107, wherein the action of the catalyst on the at least one reactant comprises oxidation, reduction, addition, cycloaddition, elimination, polymerization, depolymerization, isomerization, cyclization, hydrogenation, reductive alkylation, or combinations thereof.

### Claim 112 (depends on 107)

The method of claim 107, wherein identifying one or more of the plurality of potential chemical catalysts that alter the level of the at least one of the one or more products comprises analyzing product yields, compositions, reaction selectivity, catalyst stability, catalyst poisoning, or combinations thereof.

### Claim 113

A method of optimizing a reaction condition for a catalyst, the method comprising:
(i) providing a plurality of assay solutions, which plurality of assay solutions comprises a reactant and a catalyst;
(ii) exposing the plurality of assay solutions to one or more of a plurality of reaction conditions;
(iii) performing magnetic resonance (MRI) spectroscopy on the plurality of assay solutions, thereby detecting one or more products generated by an action of the catalyst on the reactant;
(iv) identifying one or more of the plurality of reaction conditions that alter the level of at least one of the one or more products; and
(v) analyzing the one or more of the plurality of reaction conditions, thereby optimizing the reaction condition for the catalyst.

### Claim 114 (depends on 113)

The method of claim 113, wherein the plurality of reaction conditions comprises catalyst concentration, catalyst activating agents, catalyst deactivating agents, solvent concentration, assay solution pH, pressure, temperature, electromagnetic radiation, reactant composition, length of reaction time, stop reagents, or combinations thereof.

### Claim 115 (depends on 113)

The method of claim 113, wherein analyzing the one or more of the plurality of reaction conditions comprises determining a window of operation for the catalyst.
